• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑动静脉畸形质子束放射外科治疗后辐射相关并发症的剂量-体积预测

Dose-volume prediction of radiation-related complications after proton beam radiosurgery for cerebral arteriovenous malformations.

作者信息

Barker Fred G, Butler William E, Lyons Sue, Cascio Ethan, Ogilvy Christopher S, Loeffler Jay S, Chapman Paul H

机构信息

Proton Radiosurgery Group, Neurosurgical Service, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

出版信息

J Neurosurg. 2003 Aug;99(2):254-63. doi: 10.3171/jns.2003.99.2.0254.

DOI:10.3171/jns.2003.99.2.0254
PMID:12924697
Abstract

OBJECT

The use of radiosurgery for the treatment of cerebral arteriovenous malformations (AVMs) and other lesions demands an accurate understanding of the risk of radiation-related complications. Some commonly used formulas for predicting risk are based on extrapolation from small numbers of animal experiments, pilot human treatment series, and theoretical radiobiological considerations. The authors studied the incidence of complications after AVM radiosurgery in relation to dose, volume, and other factors in a large patient series.

METHODS

A retrospective review was conducted in 1329 patients with AVM treated by Dr. Raymond Kjellberg at the Harvard Cyclotron Laboratory (HCL) between 1965 and 1993. Dose and volume were obtained from HCL records, and information about patient follow up was derived from concurrent clinical records, questionnaires, and contact with referring physicians. Multivariate logistic regression with bootstrapped confidence intervals was used. Follow up was available in 1250 patients (94%); the median follow-up duration was 6.5 years. The median radiation dose was 10.5 Gy and the median treatment volume was 33.7 cm(3). Twenty-three percent of treated lesions were smaller than 10 cm(3). Fifty-one permanent radiation-related deficits occurred (4.1%). Of 1043 patients treated with a dose predicted by the Kjellberg isoeffective centile curve to have a less than 1% complication risk, 1.8% suffered radiation-related complications. Actual complication rates were 4.7% for 128 patients treated at Kjellberg risk centile doses of 1 to 1.8%, and 34% for 61 patients treated at risk centile doses of 2 to 2.5%. The fitted logistic model showed that complication risk was related to treatment dose and volume, thalamic or brainstem location, and patient age.

CONCLUSIONS

The Kjellberg isoeffective risk centile curve significantly underpredicted actual risks of permanent complications after proton beam radiosurgery for AVMs. Actual risks were best predicted using a model that accounted for treatment dose and volume, lesion location, and patient age.

摘要

目的

使用放射外科治疗脑动静脉畸形(AVM)及其他病变需要准确了解辐射相关并发症的风险。一些常用的预测风险公式是基于少量动物实验、人体试验系列以及理论放射生物学考量的推断得出的。作者在一个大型患者系列中研究了AVM放射外科治疗后并发症的发生率与剂量、体积及其他因素的关系。

方法

对1965年至1993年间在哈佛回旋加速器实验室(HCL)由雷蒙德·凯尔伯格医生治疗的1329例AVM患者进行回顾性研究。剂量和体积数据来自HCL记录,患者随访信息来自同期临床记录、问卷调查以及与转诊医生的联系。采用带有自抽样置信区间的多变量逻辑回归分析。1250例患者(94%)有随访数据;中位随访时间为6.5年。中位放射剂量为10.5 Gy,中位治疗体积为33.7 cm³。23%的治疗病变体积小于10 cm³。发生了51例永久性辐射相关缺陷(4.1%)。在1043例按照凯尔伯格等效百分位曲线预测并发症风险低于1%进行治疗的患者中,1.8%出现了辐射相关并发症。在凯尔伯格风险百分位剂量为1%至1.8%的情况下接受治疗的128例患者,实际并发症发生率为4.7%;在风险百分位剂量为2%至2.5%的情况下接受治疗的61例患者,实际并发症发生率为34%。拟合的逻辑模型显示,并发症风险与治疗剂量、体积、丘脑或脑干位置以及患者年龄有关。

结论

凯尔伯格等效风险百分位曲线显著低估了质子束放射外科治疗AVM后永久性并发症的实际风险。使用考虑治疗剂量、体积、病变位置和患者年龄的模型能最好地预测实际风险。

相似文献

1
Dose-volume prediction of radiation-related complications after proton beam radiosurgery for cerebral arteriovenous malformations.脑动静脉畸形质子束放射外科治疗后辐射相关并发症的剂量-体积预测
J Neurosurg. 2003 Aug;99(2):254-63. doi: 10.3171/jns.2003.99.2.0254.
2
Planned two-fraction proton beam stereotactic radiosurgery for high-risk inoperable cerebral arteriovenous malformations.计划行两分次质子束立体定向放射外科治疗高危不可切除脑动静脉畸形。
Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):533-41. doi: 10.1016/j.ijrobp.2011.08.003. Epub 2011 Nov 16.
3
Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: correlation with dose distribution parameters.动静脉畸形患者放射外科治疗后脑组织的辐射诱导变化:与剂量分布参数的相关性
Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):796-808. doi: 10.1016/j.ijrobp.2003.11.033.
4
Stereotactic radiosurgery for pediatric intracranial arteriovenous malformations: the University of California at San Francisco experience.小儿颅内动静脉畸形的立体定向放射外科治疗:加利福尼亚大学旧金山分校的经验
J Neurosurg. 2002 Jul;97(1):48-55. doi: 10.3171/jns.2002.97.1.0048.
5
Pretreatment predictors of adverse radiation effects after radiosurgery for arteriovenous malformation.放射性外科治疗动静脉畸形后不良反应的预测因素。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):803-8. doi: 10.1016/j.ijrobp.2010.12.014. Epub 2011 Feb 23.
6
Clinical and radiobiological advantages of single-dose stereotactic light-ion radiation therapy for large intracranial arteriovenous malformations. Technical note.大颅内动静脉畸形单剂量立体定向轻离子放射治疗的临床及放射生物学优势。技术说明。
J Neurosurg. 2009 Nov;111(5):919-26. doi: 10.3171/2007.10.17205.
7
Gamma knife radiosurgery as a single treatment modality for large cerebral arteriovenous malformations.伽玛刀放射外科作为大型脑动静脉畸形的单一治疗方式。
J Neurosurg. 2000 Dec;93 Suppl 3:113-9. doi: 10.3171/jns.2000.93.supplement.
8
Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: dose/volume-response relations.动静脉畸形患者放射外科手术后脑组织的辐射诱导变化:剂量/体积反应关系
Strahlenther Onkol. 2004 Dec;180(12):758-67. doi: 10.1007/s00066-004-1266-6.
9
Clinical and neuroimaging outcome of cerebral arteriovenous malformations after Gamma Knife surgery: analysis of the radiation injury rate depending on the arteriovenous malformation volume.
J Neurosurg. 2008 Aug;109(2):191-8. doi: 10.3171/JNS/2008/109/8/0191.
10
Radiosurgery for arteriovenous malformations of the basal ganglia, thalamus, and brainstem.基底节、丘脑和脑干动静脉畸形的放射外科治疗。
J Neurosurg. 2004 Feb;100(2):210-4. doi: 10.3171/jns.2004.100.2.0210.

引用本文的文献

1
Dosimetric evaluation and clinical application of collimated apertures with proton beam line scanning in stereotactic radiotherapy.立体定向放射治疗中质子束线扫描准直孔径的剂量学评估及临床应用
J Appl Clin Med Phys. 2025 Jul;26(7):e70128. doi: 10.1002/acm2.70128. Epub 2025 May 29.
2
Long-term outcomes and radiation-induced complications following stereotactic radiosurgery for a left temporal arteriovenous malformation: illustrative case.立体定向放射外科治疗左颞动静脉畸形后的长期疗效及放射诱发并发症:病例展示
J Neurosurg Case Lessons. 2025 May 26;9(21). doi: 10.3171/CASE25201.
3
The evolution of stereotactic radiosurgery in neurosurgical practice.
立体定向放射外科在神经外科学中的发展。
J Neurooncol. 2021 Feb;151(3):451-459. doi: 10.1007/s11060-020-03392-0. Epub 2021 Feb 21.
4
Proton and Heavy Particle Intracranial Radiosurgery.质子和重粒子颅内放射外科手术
Biomedicines. 2021 Jan 3;9(1):31. doi: 10.3390/biomedicines9010031.
5
Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.单剂量和多剂量立体定向放射外科治疗脑的剂量/体积耐受量。
Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):68-86. doi: 10.1016/j.ijrobp.2020.08.013. Epub 2020 Sep 11.
6
An Iatrogenic Model of Brain Small-Vessel Disease: Post-Radiation Encephalopathy.医源性脑小血管病模型:放射性脑病。
Int J Mol Sci. 2020 Sep 5;21(18):6506. doi: 10.3390/ijms21186506.
7
Predictors of radiation necrosis in long-term survivors after Gamma Knife stereotactic radiosurgery for brain metastases.伽玛刀立体定向放射外科治疗脑转移瘤后长期存活者放射性坏死的预测因素
Neurooncol Pract. 2020 Jul;7(4):400-408. doi: 10.1093/nop/npz067. Epub 2019 Dec 6.
8
Radiation Necrosis in Intracranial Lesions.颅内病变中的放射性坏死
Cureus. 2020 Apr 9;12(4):e7603. doi: 10.7759/cureus.7603.
9
Estimating normal tissue toxicity in radiosurgery of the CNS: application and limitations of QUANTEC.评估中枢神经系统放射外科手术中的正常组织毒性:QUANTEC的应用与局限性
J Radiosurg SBRT. 2011;1(2):95-107.
10
Management approach for recurrent brain metastases following upfront radiosurgery may affect risk of subsequent radiation necrosis.upfront放射外科治疗后复发性脑转移瘤的管理方法可能会影响后续放射性坏死的风险。
Adv Radiat Oncol. 2016 Aug 24;1(4):294-299. doi: 10.1016/j.adro.2016.08.007. eCollection 2016 Oct-Dec.